 | • レポートコード：MRC2Q12-01826 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：化学&材料 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、フリバンセリンAPIのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 フリバンセリンAPIのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 フリバンセリンAPIの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 フリバンセリンAPIのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのフリバンセリンAPIの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のフリバンセリンAPIの売上および2028年までの予測に焦点を当てています。 フリバンセリンAPIのグローバル主要企業には、Boehringer Ingelheim、Glenmark Pharma、Chengchuang Pharmaceutical Group、JL Pharm、Apicore LLC、Jigs Chemical、Century Pharma、BOC Sciences、Axon Medchem、AdooQ BioScience、Toronto Research Chemicals、TimTec、Standardpharm、Symed Labs、Rakshit Drugsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 フリバンセリンAPI市場は、タイプとアプリケーションによって区分されます。世界のフリバンセリンAPI市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 ＞98%、＞99% 【アプリケーション別セグメント】 製薬、科学研究 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - フリバンセリンAPI製品概要 - タイプ別市場（＞98%、＞99%） - アプリケーション別市場（製薬、科学研究） - 調査の目的 ・エグゼクティブサマリー - 世界のフリバンセリンAPI販売量予測2017-2028 - 世界のフリバンセリンAPI売上予測2017-2028 - フリバンセリンAPIの地域別販売量 - フリバンセリンAPIの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別フリバンセリンAPI販売量 - 主要メーカー別フリバンセリンAPI売上 - 主要メーカー別フリバンセリンAPI価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（＞98%、＞99%） - フリバンセリンAPIのタイプ別販売量 - フリバンセリンAPIのタイプ別売上 - フリバンセリンAPIのタイプ別価格 ・アプリケーション別市場規模（製薬、科学研究） - フリバンセリンAPIのアプリケーション別販売量 - フリバンセリンAPIのアプリケーション別売上 - フリバンセリンAPIのアプリケーション別価格 ・北米市場 - 北米のフリバンセリンAPI市場規模（タイプ別、アプリケーション別） - 主要国別のフリバンセリンAPI市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのフリバンセリンAPI市場規模（タイプ別、アプリケーション別） - 主要国別のフリバンセリンAPI市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のフリバンセリンAPI市場規模（タイプ別、アプリケーション別） - 主要国別のフリバンセリンAPI市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のフリバンセリンAPI市場規模（タイプ別、アプリケーション別） - 主要国別のフリバンセリンAPI市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのフリバンセリンAPI市場規模（タイプ別、アプリケーション別） - 主要国別のフリバンセリンAPI市場規模（トルコ、サウジアラビア） ・企業情報 Boehringer Ingelheim、Glenmark Pharma、Chengchuang Pharmaceutical Group、JL Pharm、Apicore LLC、Jigs Chemical、Century Pharma、BOC Sciences、Axon Medchem、AdooQ BioScience、Toronto Research Chemicals、TimTec、Standardpharm、Symed Labs、Rakshit Drugs ・産業チェーン及び販売チャネル分析 - フリバンセリンAPIの産業チェーン分析 - フリバンセリンAPIの原材料 - フリバンセリンAPIの生産プロセス - フリバンセリンAPIの販売及びマーケティング - フリバンセリンAPIの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - フリバンセリンAPIの産業動向 - フリバンセリンAPIのマーケットドライバー - フリバンセリンAPIの課題 - フリバンセリンAPIの阻害要因 ・主な調査結果 |
It is a medication approved for the treatment of pre-menopausal women with hypoactive sexual desire disorder (HSDD)
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Flibanserin API estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Flibanserin API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Flibanserin API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Flibanserin API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Flibanserin API include Boehringer Ingelheim, Glenmark Pharma, Chengchuang Pharmaceutical Group, JL Pharm, Apicore LLC, Jigs Chemical, Century Pharma, BOC Sciences and Axon Medchem, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the Flibanserin API production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Flibanserin API by region (region level and country level), by company, by Purity and by Application. from 2017 to 2022 and forecast to 2028.
Report Scope
This latest report researches the industry structure, capacity, production, sales (consumption), revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Flibanserin API manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Flibanserin API market. Further, it explains the major drivers and regional dynamics of the global Flibanserin API market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Boehringer Ingelheim
Glenmark Pharma
Chengchuang Pharmaceutical Group
JL Pharm
Apicore LLC
Jigs Chemical
Century Pharma
BOC Sciences
Axon Medchem
AdooQ BioScience
Toronto Research Chemicals
TimTec
Standardpharm
Symed Labs
Rakshit Drugs
Market Segments
This report has explored the key segments: by Purity and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on production, price, and value for the period 2017-2028.
Flibanserin API Segment by Purity
＞98%
＞99%
Flibanserin API Segment by Application
Pharmaceutical
Scientific Research
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. This report analyzes the Flibanserin API production by region/country, and the sales (consumption) by region/country. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Flibanserin API market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Flibanserin API, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Flibanserin API, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Flibanserin API, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Flibanserin API sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Flibanserin API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Flibanserin API sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Boehringer Ingelheim, Glenmark Pharma, Chengchuang Pharmaceutical Group, JL Pharm, Apicore LLC, Jigs Chemical, Century Pharma, BOC Sciences and Axon Medchem, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Flibanserin API capacity, production/output of global and key producers (regions/countries). It provides a quantitative analysis of the capacity, production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Flibanserin API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Flibanserin API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by purity, by application and by country, sales and revenue for each segment.
Chapter 8: Europe by purity, by application and by country, sales and revenue for each segment.
Chapter 9: Asia Pacific by purity, by application and by country, sales and revenue for each segment.
Chapter 10: Latin America by purity, by application and by country, sales and revenue for each segment.
Chapter 11: Middle East and Africa by purity, by application and by country, sales and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Flibanserin API sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
1 Study Coverage
1.1 Flibanserin API Product Introduction
1.2 Market by Purity
1.2.1 Global Flibanserin API Market Size by Purity, 2017 VS 2021 VS 2028
1.2.2 ＞98%
1.2.3 ＞99%
1.3 Market by Application
1.3.1 Global Flibanserin API Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Pharmaceutical
1.3.3 Scientific Research
1.4 Study Objectives
1.5 Years Considered
2 Global Flibanserin API Production
2.1 Global Flibanserin API Production Capacity (2017-2028)
2.2 Global Flibanserin API Production by Region: 2017 VS 2021 VS 2028
2.3 Global Flibanserin API Production by Region
2.3.1 Global Flibanserin API Historic Production by Region (2017-2022)
2.3.2 Global Flibanserin API Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Flibanserin API Sales in Volume & Value Estimates and Forecasts
3.1 Global Flibanserin API Sales Estimates and Forecasts 2017-2028
3.2 Global Flibanserin API Revenue Estimates and Forecasts 2017-2028
3.3 Global Flibanserin API Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Flibanserin API Sales by Region
3.4.1 Global Flibanserin API Sales by Region (2017-2022)
3.4.2 Global Sales Flibanserin API by Region (2023-2028)
3.5 Global Flibanserin API Revenue by Region
3.5.1 Global Flibanserin API Revenue by Region (2017-2022)
3.5.2 Global Flibanserin API Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Flibanserin API Production Capacity by Manufacturers
4.2 Global Flibanserin API Sales by Manufacturers
4.2.1 Global Flibanserin API Sales by Manufacturers (2017-2022)
4.2.2 Global Flibanserin API Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Flibanserin API in 2021
4.3 Global Flibanserin API Revenue by Manufacturers
4.3.1 Global Flibanserin API Revenue by Manufacturers (2017-2022)
4.3.2 Global Flibanserin API Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Flibanserin API Revenue in 2021
4.4 Global Flibanserin API Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Flibanserin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Flibanserin API Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Purity
5.1 Global Flibanserin API Sales by Purity
5.1.1 Global Flibanserin API Historical Sales by Purity (2017-2022)
5.1.2 Global Flibanserin API Forecasted Sales by Purity (2023-2028)
5.1.3 Global Flibanserin API Sales Market Share by Purity (2017-2028)
5.2 Global Flibanserin API Revenue by Purity
5.2.1 Global Flibanserin API Historical Revenue by Purity (2017-2022)
5.2.2 Global Flibanserin API Forecasted Revenue by Purity (2023-2028)
5.2.3 Global Flibanserin API Revenue Market Share by Purity (2017-2028)
5.3 Global Flibanserin API Price by Purity
5.3.1 Global Flibanserin API Price by Purity (2017-2022)
5.3.2 Global Flibanserin API Price Forecast by Purity (2023-2028)
6 Market Size by Application
6.1 Global Flibanserin API Sales by Application
6.1.1 Global Flibanserin API Historical Sales by Application (2017-2022)
6.1.2 Global Flibanserin API Forecasted Sales by Application (2023-2028)
6.1.3 Global Flibanserin API Sales Market Share by Application (2017-2028)
6.2 Global Flibanserin API Revenue by Application
6.2.1 Global Flibanserin API Historical Revenue by Application (2017-2022)
6.2.2 Global Flibanserin API Forecasted Revenue by Application (2023-2028)
6.2.3 Global Flibanserin API Revenue Market Share by Application (2017-2028)
6.3 Global Flibanserin API Price by Application
6.3.1 Global Flibanserin API Price by Application (2017-2022)
6.3.2 Global Flibanserin API Price Forecast by Application (2023-2028)
7 North America
7.1 North America Flibanserin API Market Size by Purity
7.1.1 North America Flibanserin API Sales by Purity (2017-2028)
7.1.2 North America Flibanserin API Revenue by Purity (2017-2028)
7.2 North America Flibanserin API Market Size by Application
7.2.1 North America Flibanserin API Sales by Application (2017-2028)
7.2.2 North America Flibanserin API Revenue by Application (2017-2028)
7.3 North America Flibanserin API Sales by Country
7.3.1 North America Flibanserin API Sales by Country (2017-2028)
7.3.2 North America Flibanserin API Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Flibanserin API Market Size by Purity
8.1.1 Europe Flibanserin API Sales by Purity (2017-2028)
8.1.2 Europe Flibanserin API Revenue by Purity (2017-2028)
8.2 Europe Flibanserin API Market Size by Application
8.2.1 Europe Flibanserin API Sales by Application (2017-2028)
8.2.2 Europe Flibanserin API Revenue by Application (2017-2028)
8.3 Europe Flibanserin API Sales by Country
8.3.1 Europe Flibanserin API Sales by Country (2017-2028)
8.3.2 Europe Flibanserin API Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Flibanserin API Market Size by Purity
9.1.1 Asia Pacific Flibanserin API Sales by Purity (2017-2028)
9.1.2 Asia Pacific Flibanserin API Revenue by Purity (2017-2028)
9.2 Asia Pacific Flibanserin API Market Size by Application
9.2.1 Asia Pacific Flibanserin API Sales by Application (2017-2028)
9.2.2 Asia Pacific Flibanserin API Revenue by Application (2017-2028)
9.3 Asia Pacific Flibanserin API Sales by Region
9.3.1 Asia Pacific Flibanserin API Sales by Region (2017-2028)
9.3.2 Asia Pacific Flibanserin API Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Flibanserin API Market Size by Purity
10.1.1 Latin America Flibanserin API Sales by Purity (2017-2028)
10.1.2 Latin America Flibanserin API Revenue by Purity (2017-2028)
10.2 Latin America Flibanserin API Market Size by Application
10.2.1 Latin America Flibanserin API Sales by Application (2017-2028)
10.2.2 Latin America Flibanserin API Revenue by Application (2017-2028)
10.3 Latin America Flibanserin API Sales by Country
10.3.1 Latin America Flibanserin API Sales by Country (2017-2028)
10.3.2 Latin America Flibanserin API Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Flibanserin API Market Size by Purity
11.1.1 Middle East and Africa Flibanserin API Sales by Purity (2017-2028)
11.1.2 Middle East and Africa Flibanserin API Revenue by Purity (2017-2028)
11.2 Middle East and Africa Flibanserin API Market Size by Application
11.2.1 Middle East and Africa Flibanserin API Sales by Application (2017-2028)
11.2.2 Middle East and Africa Flibanserin API Revenue by Application (2017-2028)
11.3 Middle East and Africa Flibanserin API Sales by Country
11.3.1 Middle East and Africa Flibanserin API Sales by Country (2017-2028)
11.3.2 Middle East and Africa Flibanserin API Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Boehringer Ingelheim
12.1.1 Boehringer Ingelheim Corporation Information
12.1.2 Boehringer Ingelheim Overview
12.1.3 Boehringer Ingelheim Flibanserin API Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Boehringer Ingelheim Flibanserin API Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Boehringer Ingelheim Recent Developments
12.2 Glenmark Pharma
12.2.1 Glenmark Pharma Corporation Information
12.2.2 Glenmark Pharma Overview
12.2.3 Glenmark Pharma Flibanserin API Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Glenmark Pharma Flibanserin API Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Glenmark Pharma Recent Developments
12.3 Chengchuang Pharmaceutical Group
12.3.1 Chengchuang Pharmaceutical Group Corporation Information
12.3.2 Chengchuang Pharmaceutical Group Overview
12.3.3 Chengchuang Pharmaceutical Group Flibanserin API Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Chengchuang Pharmaceutical Group Flibanserin API Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Chengchuang Pharmaceutical Group Recent Developments
12.4 JL Pharm
12.4.1 JL Pharm Corporation Information
12.4.2 JL Pharm Overview
12.4.3 JL Pharm Flibanserin API Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 JL Pharm Flibanserin API Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 JL Pharm Recent Developments
12.5 Apicore LLC
12.5.1 Apicore LLC Corporation Information
12.5.2 Apicore LLC Overview
12.5.3 Apicore LLC Flibanserin API Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Apicore LLC Flibanserin API Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Apicore LLC Recent Developments
12.6 Jigs Chemical
12.6.1 Jigs Chemical Corporation Information
12.6.2 Jigs Chemical Overview
12.6.3 Jigs Chemical Flibanserin API Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Jigs Chemical Flibanserin API Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Jigs Chemical Recent Developments
12.7 Century Pharma
12.7.1 Century Pharma Corporation Information
12.7.2 Century Pharma Overview
12.7.3 Century Pharma Flibanserin API Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Century Pharma Flibanserin API Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Century Pharma Recent Developments
12.8 BOC Sciences
12.8.1 BOC Sciences Corporation Information
12.8.2 BOC Sciences Overview
12.8.3 BOC Sciences Flibanserin API Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 BOC Sciences Flibanserin API Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 BOC Sciences Recent Developments
12.9 Axon Medchem
12.9.1 Axon Medchem Corporation Information
12.9.2 Axon Medchem Overview
12.9.3 Axon Medchem Flibanserin API Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Axon Medchem Flibanserin API Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Axon Medchem Recent Developments
12.10 AdooQ BioScience
12.10.1 AdooQ BioScience Corporation Information
12.10.2 AdooQ BioScience Overview
12.10.3 AdooQ BioScience Flibanserin API Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 AdooQ BioScience Flibanserin API Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 AdooQ BioScience Recent Developments
12.11 Toronto Research Chemicals
12.11.1 Toronto Research Chemicals Corporation Information
12.11.2 Toronto Research Chemicals Overview
12.11.3 Toronto Research Chemicals Flibanserin API Sales, Price, Revenue and Gross Margin (2017-2022)
12.11.4 Toronto Research Chemicals Flibanserin API Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Toronto Research Chemicals Recent Developments
12.12 TimTec
12.12.1 TimTec Corporation Information
12.12.2 TimTec Overview
12.12.3 TimTec Flibanserin API Sales, Price, Revenue and Gross Margin (2017-2022)
12.12.4 TimTec Flibanserin API Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 TimTec Recent Developments
12.13 Standardpharm
12.13.1 Standardpharm Corporation Information
12.13.2 Standardpharm Overview
12.13.3 Standardpharm Flibanserin API Sales, Price, Revenue and Gross Margin (2017-2022)
12.13.4 Standardpharm Flibanserin API Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 Standardpharm Recent Developments
12.14 Symed Labs
12.14.1 Symed Labs Corporation Information
12.14.2 Symed Labs Overview
12.14.3 Symed Labs Flibanserin API Sales, Price, Revenue and Gross Margin (2017-2022)
12.14.4 Symed Labs Flibanserin API Product Model Numbers, Pictures, Descriptions and Specifications
12.14.5 Symed Labs Recent Developments
12.15 Rakshit Drugs
12.15.1 Rakshit Drugs Corporation Information
12.15.2 Rakshit Drugs Overview
12.15.3 Rakshit Drugs Flibanserin API Sales, Price, Revenue and Gross Margin (2017-2022)
12.15.4 Rakshit Drugs Flibanserin API Product Model Numbers, Pictures, Descriptions and Specifications
12.15.5 Rakshit Drugs Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Flibanserin API Industry Chain Analysis
13.2 Flibanserin API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Flibanserin API Production Mode & Process
13.4 Flibanserin API Sales and Marketing
13.4.1 Flibanserin API Sales Channels
13.4.2 Flibanserin API Distributors
13.5 Flibanserin API Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Flibanserin API Industry Trends
14.2 Flibanserin API Market Drivers
14.3 Flibanserin API Market Challenges
14.4 Flibanserin API Market Restraints
15 Key Finding in The Global Flibanserin API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer